Inhibition of DNA‑PK by gefitinib causes synergism between gefitinib and cisplatin in NSCLC-Reference-Cited by-同舟云学术

Inhibition of DNA‑PK by gefitinib causes synergism between gefitinib and cisplatin in NSCLC

Published:2020-07-27 Issue: Volume: Page:
ISSN:1019-6439
Container-title:International Journal of Oncology
language:
Short-container-title:Int J Oncol

Author:

Pan Chi¹,Duan Huijie²,Wu Yinan²,Zhu Chunpeng³,Yi Chenghao⁴,Duan Yin⁵,Lu Demin⁶,Guo Cheng²,Wu Deqi⁷,Wang Yanyan¹,Fu Xianhua⁶,Xu Jing²,Chen Yiding¹,Luo Meng²,Tian Wei¹,Pan Tao¹,Xu Wenhong²,Zhang Suzhan²,Huang Jianjin⁶

Affiliation:

1. Department of Breast Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, P.R. China

2. Cancer Institute (National Ministry of Education Key Laboratory of Cancer Prevention and Intervention), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, P.R. China

3. Department of Gastroenterology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, P.R. China

4. Department of Breast Surgery, The Second Affiliated Hospital, Nanchang University, Nanchang, Jiangxi 330006, P.R. China

5. Department of Breast Surgery, The Zhejiang Provincial Hospital of Traditional Chinese Medicine, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, P.R. China

6. Department of Medical Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, P.R. China

7. Department of Gastrointestinal Thyroid and Breast Surgery, The Shulan (Hangzhou) Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing the CD44-targeted delivery of self-assembled hyaluronan nanogel to reverse the antagonism between Cisplatin and Gefitinib in NSCLC cancer therapy;Carbohydrate Polymers;2024-11

2. Effect of dihydromyricetin combined with cisplatin on treatment of lung cancer cell A549;2023-05-05

3. An mTOR and DNA-PK dual inhibitor CC-115 hinders non-small cell lung cancer cell growth;Cell Death Discovery;2022-06-18

4. The efficacy of PI3Kγ and EGFR inhibitors on the suppression of the characteristics of cancer stem cells;Scientific Reports;2022-01-10